Review of 20-year results of ASCOT Legacy

The article presents the results of a 20-year follow-up of patients in the ASCOT Legacy study, indicating that antihypertensive and lipid-lowering therapy reduces mortality in patients with hypertension and high cardiovascular risk in the long term. In the group of patients treated with amlodipine c...

Full description

Saved in:
Bibliographic Details
Main Authors: M. B. Nagorny, A. N. Kuchmin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2023-06-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/5457
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250049033240576
author M. B. Nagorny
A. N. Kuchmin
author_facet M. B. Nagorny
A. N. Kuchmin
author_sort M. B. Nagorny
collection DOAJ
description The article presents the results of a 20-year follow-up of patients in the ASCOT Legacy study, indicating that antihypertensive and lipid-lowering therapy reduces mortality in patients with hypertension and high cardiovascular risk in the long term. In the group of patients treated with amlodipine compared with the β-blocker atenolol, there was a decrease in mean systolic and diastolic blood pressure (BP), as well as a long-term improve in the form of a decrease in the prevalence of cardiovascular events and mortality due to stroke. An important feature of therapy based on amlodipine was the reduction in BP variability. The article reflects the results of major studies that determine the possibility and effectiveness of early prescription of combined antihypertensive and lipid-lowering therapy.
format Article
id doaj-art-01fba244afda4e8b85afa82a134ae49a
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2023-06-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-01fba244afda4e8b85afa82a134ae49a2025-08-20T03:57:22Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202023-06-0128510.15829/1560-4071-2023-54573826Review of 20-year results of ASCOT LegacyM. B. Nagorny0A. N. Kuchmin1S. M. Kirov Military Medical AcademyS. M. Kirov Military Medical AcademyThe article presents the results of a 20-year follow-up of patients in the ASCOT Legacy study, indicating that antihypertensive and lipid-lowering therapy reduces mortality in patients with hypertension and high cardiovascular risk in the long term. In the group of patients treated with amlodipine compared with the β-blocker atenolol, there was a decrease in mean systolic and diastolic blood pressure (BP), as well as a long-term improve in the form of a decrease in the prevalence of cardiovascular events and mortality due to stroke. An important feature of therapy based on amlodipine was the reduction in BP variability. The article reflects the results of major studies that determine the possibility and effectiveness of early prescription of combined antihypertensive and lipid-lowering therapy.https://russjcardiol.elpub.ru/jour/article/view/5457amlodipinehypertensionblood pressureblood pressure variabilitycardiovascular riskperindoprilfixed-dose combinations
spellingShingle M. B. Nagorny
A. N. Kuchmin
Review of 20-year results of ASCOT Legacy
Российский кардиологический журнал
amlodipine
hypertension
blood pressure
blood pressure variability
cardiovascular risk
perindopril
fixed-dose combinations
title Review of 20-year results of ASCOT Legacy
title_full Review of 20-year results of ASCOT Legacy
title_fullStr Review of 20-year results of ASCOT Legacy
title_full_unstemmed Review of 20-year results of ASCOT Legacy
title_short Review of 20-year results of ASCOT Legacy
title_sort review of 20 year results of ascot legacy
topic amlodipine
hypertension
blood pressure
blood pressure variability
cardiovascular risk
perindopril
fixed-dose combinations
url https://russjcardiol.elpub.ru/jour/article/view/5457
work_keys_str_mv AT mbnagorny reviewof20yearresultsofascotlegacy
AT ankuchmin reviewof20yearresultsofascotlegacy